ABSTRACT
Dysfunctional endothelium causes more disease than any other cell type. Systemically administered RNA delivery to nonliver tissues remains challenging, in large part because there is no high-throughput method to identify nanoparticles that deliver functional mRNA to cells in vivo. Here we report a system capable of simultaneously quantifying how >100 lipid nanoparticles (LNPs) deliver mRNA that is translated into functional protein. Using this system (named FIND), we measured how >250 LNPs delivered mRNA to multiple cell types in vivo and identified 7C2 and 7C3, two LNPs that efficiently deliver siRNA, single-guide RNA (sgRNA), and mRNA to endothelial cells. The 7C3 delivered Cas9 mRNA and sgRNA to splenic endothelial cells as efficiently as hepatocytes, distinguishing it from LNPs that deliver Cas9 mRNA and sgRNA to hepatocytes more than other cell types. These data demonstrate that FIND can identify nanoparticles with novel tropisms in vivo.
Subject(s)
CRISPR-Cas Systems , Endothelial Cells/metabolism , Gene Editing , Gene Transfer Techniques , Lipids/chemistry , Nanoparticles/administration & dosage , RNA, Guide, Kinetoplastida/genetics , RNA, Messenger/genetics , Animals , Cells, Cultured , Endothelial Cells/cytology , HEK293 Cells , Hepatocytes/cytology , Hepatocytes/metabolism , High-Throughput Screening Assays , Humans , Mice , Mice, Inbred C57BL , Nanoparticles/chemistry , RNA, Guide, Kinetoplastida/chemistry , RNA, Messenger/chemistryABSTRACT
Lipid nanoparticles (LNPs) are formulated using unmodified cholesterol. However, cholesterol is naturally esterified and oxidized in vivo, and these cholesterol variants are differentially trafficked in vivo via lipoproteins including LDL and VLDL. We hypothesized that incorporating the same cholesterol variants into LNPs-which can be structurally similar to LDL and VLDL-would alter nanoparticle targeting in vivo. To test this hypothesis, we quantified how >100 LNPs made with six cholesterol variants delivered DNA barcodes to 18 cell types in wild-type, LDLR-/-, and VLDLR-/- mice that were both age-matched and female. By analyzing â¼2000 in vivo drug delivery data points, we found that LNPs formulated with esterified cholesterol delivered nucleic acids more efficiently than LNPs formulated with regular or oxidized cholesterol when compared across all tested cell types in the mouse. We also identified an LNP containing cholesteryl oleate that efficiently delivered siRNA and sgRNA to liver endothelial cells in vivo. Delivery was as-or more-efficient as the same LNP made with unmodified cholesterol. Moreover, delivery to liver endothelial cells was 3 times more efficient than delivery to hepatocytes, distinguishing this oleate LNP from hepatocyte-targeting LNPs. RNA delivery can be improved by rationally selecting cholesterol variants, allowing optimization of nanoparticle targeting.
Subject(s)
Cholesterol/chemistry , Drug Delivery Systems , Nanoparticles/chemistry , RNA, Guide, Kinetoplastida/chemistry , RNA, Small Interfering/chemistry , Animals , Cholesterol/metabolism , Drug Carriers/chemistry , Drug Carriers/metabolism , Endothelial Cells/chemistry , Endothelial Cells/metabolism , Female , Liver/chemistry , Liver/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nanoparticles/metabolism , RNA, Guide, Kinetoplastida/metabolism , RNA, Small Interfering/metabolismABSTRACT
Engineered T cells are transforming broad fields in biomedicine, yet our ability to control cellular activity at specific anatomical sites remains limited. Here we engineer thermal gene switches to allow spatial and remote control of transcriptional activity using pulses of heat. These gene switches are constructed from the heat shock protein HSP70B' (HSPA6) promoter, show negligible basal transcriptional activity, and activate within an elevated temperature window of 40-45 °C. Using engineered Jurkat T cells implanted in vivo, we use plasmonic photothermal heating to trigger gene expression at specific sites to levels greater than 200-fold. We show that delivery of heat as thermal pulse trains significantly increase cellular thermal tolerance compared to continuous heating curves with identical area-under-the-curve (AUC), enabling long-term control of gene expression in Jurkat T cells. This approach expands the toolkit of remotely controlled genetic devices for basic and translational applications in synthetic immunology.
Subject(s)
Genes, Switch , Genetic Engineering/methods , HSP70 Heat-Shock Proteins/genetics , Low-Level Light Therapy/methods , Animals , Area Under Curve , Body Temperature , Gene Expression Regulation , Hot Temperature , Humans , Jurkat Cells , Lasers , Low-Level Light Therapy/instrumentation , Mice, Nude , Nanotubes , Promoter Regions, Genetic , Surface Plasmon ResonanceABSTRACT
Collective behaviors emerge from coordinated cell-cell interactions during the morphogenesis of tissues and tumors. For instance, cells may display density-dependent phase transitions from a fluid-like "unjammed" phase to a solid-like "jammed" phase, while different cell types can "self-sort". Here, we comprehensively track single cell dynamics in mixtures of sheet-forming epithelial cells and dispersed mesenchymal cells. We find that proliferating epithelial cells nucleate multicellular clusters that coarsen at a critical density, arresting migration and strengthening spatial velocity correlations. The addition of mesenchymal cells can slow cluster formation and coarsening, resulting in more dispersed individual cells with weak spatial velocity correlations. These behaviors have analogies with a jamming-unjamming transition, where the control parameters are cell density and mesenchymal fraction. This complex interplay of proliferation, clustering and correlated migration may have physical implications for understanding epithelial-mesenchymal interactions in development and disease.
